These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 23128977

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of human papillomavirus 16 E5 on malignancy of human cervical cancer cells and the mechanism there of].
    Liao SJ, Deng DR, Xia X.
    Zhonghua Yi Xue Za Zhi; 2008 Nov 25; 88(43):3080-4. PubMed ID: 19192411
    [Abstract] [Full Text] [Related]

  • 3. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells.
    Boulenouar S, Weyn C, Van Noppen M, Moussa Ali M, Favre M, Delvenne PO, Bex F, Noël A, Englert Y, Fontaine V.
    Carcinogenesis; 2010 Mar 25; 31(3):473-80. PubMed ID: 19917629
    [Abstract] [Full Text] [Related]

  • 4. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K, Mahata S, Tyagi A, Pandey A, Verma G, Jadli M, Singh T, Singh SM, Bharti AC.
    Tumour Biol; 2016 Oct 25; 37(10):13137-13154. PubMed ID: 27449048
    [Abstract] [Full Text] [Related]

  • 5. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W, Hu Z, Zhu D, Jiang X, Yu L, Wang X, Zhang C, Wang L, Ji T, Li K, He D, Xia X, Liu D, Zhou J, Ma D, Wang H.
    Clin Cancer Res; 2014 Dec 15; 20(24):6495-503. PubMed ID: 25336692
    [Abstract] [Full Text] [Related]

  • 6. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM, Bell MC, O'Donnell EA, Gupta BK, Jaggi M, Chauhan SC.
    Mol Carcinog; 2011 Jan 15; 50(1):47-57. PubMed ID: 21061268
    [Abstract] [Full Text] [Related]

  • 7. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF, Wang N, Bi XN, Yu X, Xu XH, Wang YL, Zhao CQ, Luo B, Wang YK.
    Virol J; 2016 Apr 05; 13():60. PubMed ID: 27044426
    [Abstract] [Full Text] [Related]

  • 8. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q, Song R, Zhao C, Liu H, Yang Y, Gu S, Feng D, He J.
    Int J Cancer; 2019 Apr 01; 144(7):1619-1632. PubMed ID: 30230542
    [Abstract] [Full Text] [Related]

  • 9. HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7.
    Liao S, Deng D, Hu X, Wang W, Li L, Li W, Zhou J, Xu G, Meng L, Wang S, Ma D.
    Int J Mol Med; 2013 Jan 01; 31(1):120-8. PubMed ID: 23128250
    [Abstract] [Full Text] [Related]

  • 10. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA.
    Wu S, Meng L, Wang S, Wang W, Xi L, Tian X, Chen G, Wu Y, Zhou J, Xu G, Lu Y, Ma D.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2032-7. PubMed ID: 16609012
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J, Xu G, Meng L, Lu Y, Wang S, Ma D.
    Apoptosis; 2008 Feb 01; 13(2):273-81. PubMed ID: 18060502
    [Abstract] [Full Text] [Related]

  • 15. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R, Kausar H, Munjal C, Gupta RC.
    Carcinogenesis; 2011 Nov 01; 32(11):1697-705. PubMed ID: 21859835
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J, Li B, Peng C, Wang F, Fu Z, Zhou C, Hong D, Ye F, Lü W, Xie X.
    Antiviral Res; 2013 May 01; 98(2):305-13. PubMed ID: 23523766
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
    Kim MK, Kim HS, Kim SH, Oh JM, Han JY, Lim JM, Juhnn YS, Song YS.
    Biochem Pharmacol; 2010 Dec 15; 80(12):1930-5. PubMed ID: 20643111
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
    Wei XM, Wang Q, Gao SJ, Sui L.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Apr 15; 46(4):260-5. PubMed ID: 21609578
    [Abstract] [Full Text] [Related]

  • 19. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.
    Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, Fujino M, Nishihara T, Ikeda Y, Nasu Y, Saigo K, Yoshinouchi M.
    Cancer Gene Ther; 2008 Mar 15; 15(3):140-53. PubMed ID: 18157144
    [Abstract] [Full Text] [Related]

  • 20. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
    Ren C, Cheng X, Lu B, Yang G.
    Eur J Cancer; 2013 Dec 15; 49(18):3889-99. PubMed ID: 23953057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.